CC
AZN icon

Chicago Capital’s AstraZeneca AZN Stock Holding History

Chicago Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,347
Closed -$248K – 358
2025
Q4 		$248K Sell
1,347
-95
-7% -$16.7K 0.01% 323
2025
Q3 		$221K Sell
1,442
-316
-18% -$47.8K 0.01% 340
2025
Q2 		$246K Buy
1,758
+137
+8% +$19.2K 0.01% 324
2025
Q1 		$238K Sell
1,621
-525
-24% -$76K 0.01% 310
2024
Q4 		$281K Sell
2,146
-757
-26% -$106K 0.01% 282
2024
Q3 		$452K Sell
2,903
-362
-11% -$58.4K 0.01% 231
2024
Q2 		$509K Sell
3,265
-106
-3% -$16K 0.02% 223
2024
Q1 		$457K Sell
3,371
-8,789
-72% -$1.16M 0.01% 226
2023
Q4 		$1.64M Buy
+12,160
New +$1.58M 0.06% 122

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Chicago Capital's AZN Position: Q1 2026 in Review

Chicago Capital sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 1,347 shares — an estimated $248K sold.

Chicago Capital first reported a position in AZN in Q4 2023 and held it in 9 quarters. The position peaked at $1.64M in Q4 2023. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Chicago Capital reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Chicago Capital sold 1,347 AstraZeneca shares in Q1 2026, an estimated $248K.
  • Chicago Capital first reported a position in AstraZeneca in Q4 2023 and held it in 9 quarters.
  • Chicago Capital's AstraZeneca position peaked at $1.64M in Q4 2023.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Chicago Capital's 13F filing for Q1 2026, filed 24 Apr 2026.